Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs
- PMID: 22201588
- DOI: 10.2174/138920112800624418
Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs
Abstract
Due to the molecular complexity of cancer, combination therapy is becoming increasingly important for better long-term prognosis with fewer side effects. To further increase the therapeutic effects, advanced drug delivery systems (DDSs), capable of simultaneously delivering multiple drugs to the site of action with specific time-programmed release profiles, are important requirements. Nanocarriers for the simultaneous co-delivery of multiple chemical drugs in combination therapy have been extensively reviewed. Here we focus on the nanotechnology enabled DDSs for the simultaneous co-delivery of therapeutic genes and chemical drugs for cancer treatment. The opportunities for this combination strategy and their challenges will be discussed.
Similar articles
-
Drug and gene co-delivery systems for cancer treatment.Biomater Sci. 2015 Jul;3(7):1035-49. doi: 10.1039/c4bm00369a. Epub 2015 Feb 6. Biomater Sci. 2015. PMID: 26221938
-
Selenium nanoparticles: potential in cancer gene and drug delivery.Nanomedicine (Lond). 2017 May;12(9):1075-1089. doi: 10.2217/nnm-2017-0024. Epub 2017 Apr 25. Nanomedicine (Lond). 2017. PMID: 28440710 Review.
-
Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.Ther Deliv. 2018 Oct;9(10):751-773. doi: 10.4155/tde-2018-0041. Ther Deliv. 2018. PMID: 30277132 Review.
-
Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.Curr Drug Metab. 2012 Oct;13(8):1087-96. doi: 10.2174/138920012802849995. Curr Drug Metab. 2012. PMID: 22380013 Review.
-
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.Trends Pharmacol Sci. 2014 Nov;35(11):556-66. doi: 10.1016/j.tips.2014.09.008. Epub 2014 Oct 16. Trends Pharmacol Sci. 2014. PMID: 25441774 Review.
Cited by
-
Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers.Funct Integr Genomics. 2024 Sep 28;24(5):177. doi: 10.1007/s10142-024-01459-z. Funct Integr Genomics. 2024. PMID: 39340586 Review.
-
Materials innovation for co-delivery of diverse therapeutic cargos.RSC Adv. 2013 Dec 21;3(47):24794-24811. doi: 10.1039/C3RA43094D. RSC Adv. 2013. PMID: 24818000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical